NCT00535015View on ClinicalTrials.gov

Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
AnorexiaCachexiaWeight LossCarcinoma, Non-Small-Cell Lung
Interventions
DRUG

Betamarc

2 tabs BID

Trial Locations (6)

Unknown

Queen Elizabeth Hospital, Hong Kong

Tuen Mun Hospital, Hong Kong

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Cathay General Hospital, Taipei

Taipei Medical University Muncipal Wan Fang Hospital, Taipei

Sponsors

Lead Sponsor

Anaborex
All Listed Sponsors
lead

Anaborex

INDUSTRY

NCT00535015 - Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter